ACS Medicinal Chemistry Letters p. 43 - 47 (2012)
Update date:2022-08-05
Topics:
Meyer, Esmeralda V. S.
Holt, Jason J.
Girard, Kathryn R.
Ballie, Mark T.
Bushnev, Anatoliy S.
Lapp, Stacey
Menaldino, David S.
Arrendale, Richard F.
Reddy, G. Prabhakar
Evers, Taylor J.
Howard, Randy B.
Culver, Deborah G.
Liotta, Dennis C.
Galinski, Mary R.
Natchus, Michael G.
Plasmodium-infected erythrocytes have been shown to employ sphingolipids from both endogenous metabolism as well as existing host pools. Therapeutic agents that limit these supplies have thus emerged as intriguing, mechanistically distinct putative targets for the treatment of malaria infections. In an initial screen of our library of sphingolipid pathway modulators for efficacy against two strains of the predominant human malaria species Plasmodium falciparum and Plasmodium knowlesi, a series of orally available, 1-deoxysphingoid bases were found to possess promising in vitro antimalarial activity. To better understand the structural requirements that are necessary for this observed activity, a second series of modified analogues were prepared and evaluated. Initial pharmacokinetic assessments of key analogues were investigated to evaluate plasma and red blood cell concentrations in vivo.
View MoreChengdu Cogon Bio-tech Co., Ltd.
Contact:86-28-85171192
Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Feis International Trade Co,. Ltd
Contact:13961823444-18235944442
Address:Wuxi jiangsu
Shanghai Sunwise Chemical Co., Ltd
website:http://www.sunwisechem.com
Contact:86-021-33883180
Address:Room 10E, Building G, Westlink Center, No. 2337 Gudai Road, Minhang District, Shanghai, China PC: 201100
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd
Contact:+86-517-86283327
Address:9 North Hantai Road, Huaian, China
Contact:+86 18616952870
Address:Area
Doi:10.1080/00397911.2020.1802760
(2020)Doi:10.1246/cl.1992.1095
(1992)Doi:10.1055/s-0030-1289519
(2011)Doi:10.1246/cl.2011.1069
(2011)Doi:10.1002/ejoc.201700384
(2017)Doi:10.1016/j.tet.2011.11.004
(2012)